Vico Therapeutics, a neurology-focused genetic medicine company, has appointed Micah Mackison as CEO. Mackison brings significant biotechnology and pharmaceutical leadership experience to Vico. He joins from Locanabio, an RNA-targeted gene therapy company, where he was chief business officer and executive VP of Strategy and Corporate Development. At Locanabio, Mackison was instrumental in setting strategy and raising capital….
©2023 All rights reserved LaingBuisson 
